AHSCT
基本解释
- 造血乾細胞移植
英汉例句
- The preliminary result suggested that AHSCT could prolong the disease - free survival for AL, HD and ALC.
初步結果提示AHSCT能延長AL、HD和ALC患者的無病存活期。 - Autologous hematopoietic stem cell transplantation(AHSCT)
自躰造血乾細胞移植 - 5 AL and 1 HD were still in continuous complete remission to 450, 313, 276, 112, 81 and 171 days after AHSCT respectively, intracrania1 metastases relapsed in ALC after 1l5 days of complete remission.
5例AL和1例HD已分別持續完全緩解450天、313天、276天、112天、81天和171天; 1例則ALC患者在移植後完全緩解115天後出現顱內複發。